Medical Innovation Exchange

ESMO: Relay spotlights expanded FGFR2 inhibitor data it hopes will pave accelerated approval

https://www.fiercebiotech.com/biotech/esmo-relay-hits-dose-bullseye-its-fgfr2-inhibitor-barrels-along-accelerated-approval

Leave a Comment

Your email address will not be published.

Leave the field below empty!